• About
  • Meet The Team
  • Privacy Policy
Saturday, January 16, 2021

Stocks Telegraph
  • Login
  • Home
  • Featured
  • Investing
  • Morning News
  • Mid Day Movers
No Result
View All Result
Stocks Telegraph
No Result
View All Result

Why Co-Diagnostics Inc (CODX) Stock Bullish Reversal Could Mark the Start of a New Uptrend

Company has expanded its relationship with Arches Research Inc

by Nicholas K
September 8, 2020
in Featured, Mid Day Movers
Share on FacebookShare on Twitter

Its good day for Co-Diagnostics Inc [NASDAQ:CODX] investors. After several months in the red, the stock has rocketed today and is currently up by 31%. The rally follows the company’s announcement that it had made an agreement with Arches Research Inc for the expansion of Arche’s COVID-19 testing services. This will be implemented using Co-Diagnostics’ test kit called Logix Smart.

The deal is a continuation of a relationship that started earlier in the year when Arches Research began using the Co-Diagnostics kits for testing. The signing of the deal comes just days after a 3rd party study on the kits concluded that their performance was good and that they could be used in smoothening out the process of reopening workplaces, schools, and other amenities.

Commenting on the agreement, Co-Diagnostics CEO Dwight Egan stated that they were happy with the expanded relationship with one of the company’s most valued lab clients. He added that they were optimistic that the expanded relationship would open new opportunities to sell not just test kits, but other diagnostic products that the company was working on. Some of the products that it has under development include the upcoming Logix Smart Flu A/ Flu B and COVID-19 kits.

What next?

With this deal in place, this stock’s current bullish reversal could mark the start of a new uptrend. That’s because, with the expanded deal, the company’s revenues will grow in coming quarters. This will mean a higher intrinsic value for the company and by extension its price.  On top of that, investors anticipating stronger earnings in the near-term are likely to keep bidding up the stock price in the near-term. This is already happening as can be seen in the sustained increase in price since the company announced the expanded deal.

There is also the fact that with the 3rd party validation of the company’s test kits, other companies and even governments are likely to start making their orders for its COVID-19 test kits. That’s because, while the world is awaiting a vaccine, testing remains the most effective way to fully get the economy working optimally again in the near-term. It is through testing that establishments that deal with lots of people can reopen safely, by isolating those who have COVID-19 from the rest of society. Testing also presents an opportunity for governments to understand the patterns of the disease and model it for policy decision-making on COVID-19.

About Co-Diagnostics Inc

Co-Diagnostics Inc is a molecular diagnostics corporation. It is based in Salt Lake, Utah.

Get The Best Stocks To Trade Every Day!

Join now to get the Stockstelegraph.com pre-market morning brief 100% free

Tags: Co-DiagnosticsCODXCODX StockMid day moversNASDAQ: CODX

Related Posts

Top 15 Information Technology Stocks You Should Be Holding
Featured

Why Momo Inc (MOMO) Is Attracting Investors?

January 14, 2021
Telecom Stocks to Look Out for in 2021
Featured

Telecom Stocks to Look Out for in 2021

January 13, 2021
TG Therapeutics (NASDAQ: TGTX) Ublituximab Receives Fast Track Designation In US
Featured

Why T2 Biosystems Inc. (TTOO) is stock surging in the Pre-market hours today?

January 12, 2021
Top 20 Banking Industry Stocks For October 2020
Featured

Are These The Best Battery Stocks To Buy This Year

January 11, 2021
Blonder Tongue Receives U.S. Patent Grant For DMM Series Of Products
Featured

Can We Expect Growth From General Electric (GE) In 2021?

January 11, 2021
Beasley Broadcast Group (NASDAQ: BBGI) Announces Operating Results
Featured

Where The Li Auto (LI), XPeng (XPEV) Stocks Are Heading To

January 8, 2021
Next Post
Watch these Stocks Today: US Futures Pointing A Slightly higher Open

15 Of The Best Stock In Software Application Industry You Should Be Holding Right Now

Early Morning Vibes: The 4 Best Stocks To Buy Now

Blonder Tongue Receives U.S. Patent Grant For DMM Series Of Products
by Shan Zee
January 14, 2021
0

American stock markets ended trading largely in the green zone on January 13. The S&P 500 index improved to 3810...

Read more

Early Morning Vibes: Check Out These 4 hot Stocks Right Now

GILT Stock
by Shan Zee
January 12, 2021
0

On January 11, American stock markets closed in the red. The S & P500 index fell 0.66% to 3800 points,...

Read more

Early Morning Vibes: Watch These 4 Stocks Today

Beasley Broadcast Group (NASDAQ: BBGI) Announces Operating Results
by Shan Zee
January 13, 2021
0

The US stock indexes were traded in small ranges on January 12. The S&P 500 has risen symbolically by 0.04%...

Read more

Early Morning Vibes: 4 Stocks We Like for Friday

by Shan Zee
January 15, 2021
0

On January 14, the American stock indices closed in the red. The S&P 500 index dropped 0.38% to 3796 points,...

Read more

Early Morning Vibes: 4 Top Trending Stocks To Watch For Monday

GEVO Inc [GEVO]  – A Top Stock To Watch For The Remainder Of 2020
by Shan Zee
January 11, 2021
0

Last week indices in the United States managed to set fresh records on the price boards. Interestingly, we saw Wall...

Read more
  • About
  • Meet The Team
  • Privacy Policy

© 2020 Stocks Telegraph - All Rights Reserved

No Result
View All Result
  • Home
  • Featured
  • Investing
  • Morning News
  • Mid Day Movers

© 2020 Stocks Telegraph - All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Get The Best Stocks To Trade Every Day!

Join now to get the Stockstelegraph.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.